Detalhe da pesquisa
1.
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 70(5): e30251, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789545
2.
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.
Pediatr Blood Cancer
; 69(1): e29341, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34532968
3.
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
Pediatr Blood Cancer
; 65(7): e27035, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512900
4.
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Nature
; 481(7380): 157-63, 2012 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237106
5.
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
Blood
; 126(13): 1575-84, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26215111
6.
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.
Haematologica
; 102(12): 2058-2068, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28883080
7.
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS.
Haematologica
; 107(3): 759-764, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854279
8.
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Blood
; 124(15): 2400-7, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145343
9.
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Pediatr Blood Cancer
; 63(12): 2096-2103, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511899
10.
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy.
Br J Haematol
; 168(1): 94-101, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25164427
11.
Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.
Acta Neuropathol
; 140(6): 963-965, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099686
12.
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.
Br J Haematol
; 166(2): 254-259, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24661089
13.
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.
Blood
; 130(7): 943-945, 2017 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28674028
14.
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Blood
; 119(16): 3705-11, 2012 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22378848
15.
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
Blood
; 120(8): 1581-8, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22649108
16.
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.
Blood
; 120(16): 3187-205, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22879540
17.
Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion.
Acta Neuropathol
; 137(1): 179-181, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465258
18.
t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
Haematologica
; 99(5): 865-72, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24441146
19.
The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(1): 81-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23956224
20.
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(4): 647-52, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24127439